| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $59K | -86.6% |
| R&D Expense | $50.1M | +105.0% |
| SG&A Expense | $22.9M | +32.8% |
| Operating Income | -$72.9M | -6.4% |
| Pre-tax Income | -$78.1M | -123.0% |
| Income Tax | $165K | +44.7% |
| Net Income | -$78.3M | -122.8% |
| EPS (Basic) | -$5.84 | +26.4% |
| EPS (Diluted) | -$5.84 | +72.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.9M | -88.2% |
| Short-term Investments | $82.5M | — |
| Current Assets | $105.3M | -24.2% |
| Total Assets | $116.5M | -22.7% |
| Current Liabilities | $12.9M | +85.9% |
| Total Liabilities | $33.4M | +88.8% |
| Stockholders' Equity | $83.0M | -37.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.5M | -4.9% |
| Investing Cash Flow | -$81.7M | — |
| Financing Cash Flow | $14.6M | -91.7% |